AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36198841 — intervention group
Group type: COMPARATOR
Intervention: Labels: disc bulge, degeneration, arthritis
Number of subjects: 1447
Study 36198841 — intervention group
Group type: EXPERIMENTAL
Intervention: Labels: non-specific LBP, episode of back pain
Number of subjects: 1447
Study 34587702 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose red yeast rice (200 mg/day) containing 2 mg monacolin K
Number of subjects: 18
Study 34587702 — intervention group
Group type: COMPARATOR
Intervention: Diet therapy alone
Number of subjects: 18
Study 32764818 — intervention group
Group type: EXPERIMENTAL
Intervention: Active workstation (treadmill or cycling desk)
Number of subjects: 137
Study 32764818 — intervention group
Group type: COMPARATOR
Intervention: Seated session
Number of subjects: 137
Study 34737863 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (community health workers and Ethiopian Orthodox priests providing outreach and counseling)
Number of subjects: 18
Study 36064438 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoKinetics dosing for ciprofloxacin
Number of subjects: 252
Study 36064438 — intervention group
Group type: COMPARATOR
Intervention: Standard dosing for ciprofloxacin (Control)
Number of subjects: 252
Study 33836830 — intervention group
Group type: COMPARATOR
Intervention: Caucasian prediction equation
Number of subjects: 704
Study 33836830 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethiopian ethnic-specific BF% prediction equation
Number of subjects: 704
Study 34265777 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTi) followed by Cognitive Processing Therapy (CPT)
Number of subjects: 110
Study 34265777 — intervention group
Group type: COMPARATOR
Intervention: Attention Control followed by Cognitive Processing Therapy (CPT)
Number of subjects: 110
Study 32380012 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for IPV by health care professionals
Number of subjects: 17
Study 32380012 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassionate care in IPV screening
Number of subjects: 17
Study 32380012 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of dynamic responses of IPV survivors
Number of subjects: 17
Study 36429945 — intervention group
Group type: EXPERIMENTAL
Intervention: New auditory feedback device for basic hands-on CPR training
Number of subjects: 100
Study 34712679 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinhua Qinggan granules combined with antiviral drugs
Number of subjects: 123
Study 34712679 — intervention group
Group type: COMPARATOR
Intervention: Antiviral drugs alone (Western medicine group)
Number of subjects: 123
Study 32678782 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D cube task at near distance (0.3 m)
Number of subjects: 20
Study 32678782 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D cube task at middle distance (0.6 m)
Number of subjects: 20
Study 32678782 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-browsing task with medium window size (default: 1.0 × 1.1 m)
Number of subjects: 20
Study 32678782 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D cube and web-browsing tasks at near distance or large window size
Number of subjects: 20
Study 32678782 — intervention group
Group type: EXPERIMENTAL
Intervention: AR interactions with far target distance
Number of subjects: 20
Study 32678782 — intervention group
Group type: EXPERIMENTAL
Intervention: Near to middle distance (less than 0.6 m) or medium to large window size (greater than 1.0 × 1.1 m)
Number of subjects: 20
Study 34041634 — intervention group
Group type: EXPERIMENTAL
Intervention: sugammadex (2mg/kg)
Number of subjects: 38
Study 34041634 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 38
Study 33556963 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 1000000
Study 33556963 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 1000000
Study 33556963 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Pressure (PP)
Number of subjects: 1000000
Study 34617398 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study 34617398 — intervention group
Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 0
Study 34617398 — intervention group
Group type: COMPARATOR
Intervention: Lixi
Number of subjects: 0
Study 34726653 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-family room (SFR)
Number of subjects: 71
Study 34726653 — intervention group
Group type: COMPARATOR
Intervention: Open-bay (OB)
Number of subjects: 71
Study 32094442 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional somatic syndromes (FSS)
Number of subjects: 1590
Study 32094442 — intervention group
Group type: EXPERIMENTAL
Intervention: Irritable bowel syndrome
Number of subjects: 1590
Study 32094442 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic widespread pain
Number of subjects: 1590
Study 32094442 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic fatigue
Number of subjects: 1590
Study 32094442 — intervention group
Group type: EXPERIMENTAL
Intervention: Whiplash associated disorders
Number of subjects: 1590
Study 32094442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple chemical sensitivity
Number of subjects: 1590
Study 32094442 — intervention group
Group type: EXPERIMENTAL
Intervention: Bodily distress syndrome (BDS)
Number of subjects: 1590
Study 32094442 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic agreement of FSS and BDS
Number of subjects: 1590
Study 32094442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-syndromatic FSS and multi-organ BDS
Number of subjects: 1590
Study 34475191 — intervention group
Group type: EXPERIMENTAL
Intervention: LetSync mobile health app intervention
Number of subjects: 160
Study 34475191 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control arm
Number of subjects: 160
Study 32017923 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 151
Study 32017923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 34515113 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 169
Study 34515113 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 169
Study 34370610 — intervention group
Group type: EXPERIMENTAL
Intervention: TSTM (The Secret Trail of Moon) VR serious videogame
Number of subjects: 105
Study 34370610 — intervention group
Group type: EXPERIMENTAL
Intervention: Online chess training (therapeutic chess)
Number of subjects: 105
Study 34370610 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 105
Study 36013168 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound-guided therapy (LUS)
Number of subjects: 79
Study 36013168 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 79
Study 36013168 — intervention group
Group type: EXPERIMENTAL
Intervention: LUS
Number of subjects: 79
Study 36013168 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 79
Study 33151350 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (attention to tactile stimuli)
Number of subjects: 80
Study 33151350 — intervention group
Group type: COMPARATOR
Intervention: Control group (attention to a video game)
Number of subjects: 80
Study 34702772 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pretreatment ctDNA
Number of subjects: 34
Study 34702772 — intervention group
Group type: EXPERIMENTAL
Intervention: Early increase in ctDNA at week 2 compared with baseline
Number of subjects: 34
Study 34702772 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA counts or clearance at week 4 or 7
Number of subjects: 34
Study 34702772 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment ctDNA values
Number of subjects: 34
Study 34702772 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA values at week 2
Number of subjects: 34
Study 34702772 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA and imaging metrics
Number of subjects: 34
Study 34833411 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspirate Concentrate (BMAC)
Number of subjects: 175
Study 34833411 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma (PRP)
Number of subjects: 175
Study 34833411 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA)
Number of subjects: 175
Study 36086764 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 1.0 ng/mL with midazolam
Number of subjects: 80
Study 36086764 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 2.0 ng/mL with midazolam
Number of subjects: 80
Study 33878132 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomophobia Questionnaire (NMP-Q)
Number of subjects: 2260
Study 33878132 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 2260
Study 33878132 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 2260
Study 33878132 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia
Number of subjects: 2260
Study 35476651 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high-flow therapy
Number of subjects: 202
Study 35476651 — intervention group
Group type: COMPARATOR
Intervention: Standard care (no nasal high-flow therapy or supplemental oxygen)
Number of subjects: 202
Study 34886454 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Temperance Scale
Number of subjects: 860
Study 32773834 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper-based cases
Number of subjects: 27
Study 32773834 — intervention group
Group type: COMPARATOR
Intervention: Virtual patient cases
Number of subjects: 27
Study 36242928 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNC plus five 30-minute physiotherapy-led NIV sessions
Number of subjects: 130
Study 36242928 — intervention group
Group type: COMPARATOR
Intervention: Continuous HFNC for 48-hours following surgical extubation
Number of subjects: 130
Study 33368963 — intervention group
Group type: COMPARATOR
Intervention: 800 IU vitamin D3
Number of subjects: 251
Study 33368963 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D3
Number of subjects: 251
Study 34568236 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum CECT7894 and Pediococcus pentosaceus CECT8330 (1 × 10^9 CFU)
Number of subjects: 112
Study 34568236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 33909090 — intervention group
Group type: EXPERIMENTAL
Intervention: Texture analysis based on unenhanced CT (UECT)
Number of subjects: 104
Study 32008947 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambrisentan
Number of subjects: 31
Study 33181560 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC) with a flow rate of 2 L kg‐1 min‐1
Number of subjects: 78
Study 33181560 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen therapy (Control)
Number of subjects: 78
Study 33181560 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (HFNC and Control)
Number of subjects: 78
Study 32170769 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib consolidation (BC) - 1.3 mg/m2 IV days 1, 4, 8, 11 of a 3-week cycle for four cycles
Number of subjects: 151
Study 32170769 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib maintenance (BM) - 1.6 mg/m2 IV once weekly × 4 every 8 weeks for 18 months
Number of subjects: 151
Study 32170769 — intervention group
Group type: COMPARATOR
Intervention: Control group from CALGB/Alliance 59909
Number of subjects: 151
Study 32170769 — intervention group
Group type: EXPERIMENTAL
Intervention: MRD-negative post-induction
Number of subjects: 151
Study 32170769 — intervention group
Group type: EXPERIMENTAL
Intervention: High risk proliferation signature
Number of subjects: 151
Study 35344520 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 626
Study 33671257 — intervention group
Group type: EXPERIMENTAL
Intervention: WNV infection
Number of subjects: 89
Study 33671257 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine profiles
Number of subjects: 89
Study 33671257 — intervention group
Group type: EXPERIMENTAL
Intervention: WNV participants with CKD
Number of subjects: 89
Study 32568897 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based tutor
Number of subjects: 0
Study 32568897 — intervention group
Group type: COMPARATOR
Intervention: Textbook learning
Number of subjects: 0
Study 35100614 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP) monitoring
Number of subjects: 6
Study 35100614 — intervention group
Group type: COMPARATOR
Intervention: Ultraviolet fluorescent marker (UV/F)
Number of subjects: 6
Study 33466606 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 40
Study 33466606 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Vibration (MV)
Number of subjects: 40
Study 33466606 — intervention group
Group type: EXPERIMENTAL
Intervention: Percussion Therapy (PT)
Number of subjects: 40
Study 33466606 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Roller (FR)
Number of subjects: 40
Study 34698558 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT+PBM‐T
Number of subjects: 36
Study 34698558 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT+PBM‐T+ILIB
Number of subjects: 36
Study 34698558 — intervention group
Group type: EXPERIMENTAL
Intervention: ILIB
Number of subjects: 36
Study 33471581 — intervention group
Group type: EXPERIMENTAL
Intervention: Antecedent-based techniques (stimulus control)
Number of subjects: 90
Study 33471581 — intervention group
Group type: EXPERIMENTAL
Intervention: Consequent-based techniques (contingency management)
Number of subjects: 90
Study 33471581 — intervention group
Group type: COMPARATOR
Intervention: Control condition (waitlist)
Number of subjects: 90
Study 35511887 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm-crank exercise training (ACT)
Number of subjects: 45
Study 35511887 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking training (WT)
Number of subjects: 45
Study 35511887 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 32823974 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin and mineral supplement (Redoxon® VI, Singapore) taken daily for 12 weeks
Number of subjects: 0
Study 32823974 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (inactive) taken daily for 12 weeks
Number of subjects: 0
Study 35427519 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of uncomplicated acute malnutrition
Number of subjects: 234
Study 35427519 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 234
Study 32255250 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided stellate ganglion blockades (us-SGBs)
Number of subjects: 105
Study 32719525 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% polyhexamethylene biguanide (PHMB) and 0.02% chlorhexidine (BG)
Number of subjects: 23
Study 32719525 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% voriconazole (VZ)
Number of subjects: 23
Study 32979077 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/d DHA for 6 months
Number of subjects: 106
Study 32979077 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 106
Study 32532761 — intervention group
Group type: EXPERIMENTAL
Intervention: Micropulse laser therapy (MLT)
Number of subjects: 33
Study 32532761 — intervention group
Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 33
Study 36279159 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app group
Number of subjects: 109
Study 36279159 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 109
Study 36279159 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 109
Study 33444588 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/d)
Number of subjects: 1032
Study 33444588 — intervention group
Group type: COMPARATOR
Intervention: Placebo Vitamin D
Number of subjects: 1032
Study 33444588 — intervention group
Group type: EXPERIMENTAL
Intervention: Marine n-3 fatty acid (1 g/d)
Number of subjects: 1032
Study 33444588 — intervention group
Group type: COMPARATOR
Intervention: Placebo n-3 fatty acid
Number of subjects: 1032
Study 34762734 — intervention group
Group type: EXPERIMENTAL
Intervention: GA intervention
Number of subjects: 541
Study 34762734 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 541
Study 33413588 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 8 mg/kg
Number of subjects: 387
Study 33413588 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 7.5-20 mg/kg
Number of subjects: 387
Study 33413588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 387
Study 35533220 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message-delivered cardiac education and support
Number of subjects: 1424
Study 35533220 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1424
Study 32994063 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini Percutaneous Nephrolithotomy (mPNL)
Number of subjects: 1980
Study 32994063 — intervention group
Group type: COMPARATOR
Intervention: Standard Percutaneous Nephrolithotomy (sPNL)
Number of subjects: 1980
Study 33212231 — intervention group
Group type: EXPERIMENTAL
Intervention: PMDI (ropivacaine, epinephrine, ketoprofen)
Number of subjects: 59
Study 33212231 — intervention group
Group type: COMPARATOR
Intervention: Control (no injection)
Number of subjects: 59
Study 32096595 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 50
Study 32096595 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 50
Study 34345168 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention targeting caregivers (14 psychoeducational group sessions over 5 days)
Number of subjects: 142
Study 34345168 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 142
Study 35763974 — intervention group
Group type: EXPERIMENTAL
Intervention: High groove music during rhythmic auditory stimulation (RAS)
Number of subjects: 0
Study 35763974 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized walking with high groove music
Number of subjects: 0
Study 35763974 — intervention group
Group type: COMPARATOR
Intervention: Unfamiliar stimuli while walking
Number of subjects: 0
Study 33683325 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 days of high-dose amoxicillin followed by 5 days of placebo
Number of subjects: 281
Study 33683325 — intervention group
Group type: COMPARATOR
Intervention: 5 days of high-dose amoxicillin followed by a different formulation of 5 days of high-dose amoxicillin
Number of subjects: 281
Study 32388274 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 g of cod fillets per week
Number of subjects: 137
Study 32388274 — intervention group
Group type: COMPARATOR
Intervention: Control (continued habitual diet)
Number of subjects: 137
Study 35170539 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant steroid therapy (10-12 weeks)
Number of subjects: 200
Study 35170539 — intervention group
Group type: COMPARATOR
Intervention: Control (routine postoperative treatment)
Number of subjects: 200
Study 35157646 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality training (Group A)
Number of subjects: 52
Study 35157646 — intervention group
Group type: COMPARATOR
Intervention: Task-oriented training (Group B)
Number of subjects: 52
Study 32575480 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Bloc-R
Number of subjects: 27
Study 32575480 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 27
Study 32575480 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 34407034 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive virtual walking intervention
Number of subjects: 27
Study 34407034 — intervention group
Group type: COMPARATOR
Intervention: Passive, noninteractive virtual walking condition (control)
Number of subjects: 27
Study 34798060 — intervention group
Group type: EXPERIMENTAL
Intervention: Cagrilintide 0.3-4.5 mg
Number of subjects: 706
Study 34798060 — intervention group
Group type: EXPERIMENTAL
Intervention: Cagrilintide 4.5 mg
Number of subjects: 706
Study 34798060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 706
Study 34798060 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 706
Study 34129074 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhesive bulk-fill restorative (SABF)
Number of subjects: 30
Study 34129074 — intervention group
Group type: COMPARATOR
Intervention: Conventional bulk-fill composite (FOBF)
Number of subjects: 30
Study 34233667 — intervention group
Group type: EXPERIMENTAL
Intervention: CMT positive milk samples
Number of subjects: 460
Study 34233667 — intervention group
Group type: EXPERIMENTAL
Intervention: S. aureus isolates
Number of subjects: 460
Study 34233667 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA identification
Number of subjects: 460
Study 34233667 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall MRSA prevalence
Number of subjects: 460
Study 34233667 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic sensitivity to Cefazolin
Number of subjects: 460
Study 34233667 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic sensitivity to Tetracycline
Number of subjects: 460
Study 34233667 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance to Ampicillin
Number of subjects: 460
Study 34233667 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidrug resistance
Number of subjects: 460
Study 35027029 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth-delivered anti-inflammatory dietary education intervention (9-week duration, 1:1 consultations at baseline, 3- and 6-week follow-up).
Number of subjects: 28
Study 35027029 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth-delivered anti-inflammatory dietary education intervention.
Number of subjects: 28
Study 32052313 — intervention group
Group type: EXPERIMENTAL
Intervention: DRL_RI
Number of subjects: 276
Study 32052313 — intervention group
Group type: COMPARATOR
Intervention: RTX-US
Number of subjects: 276
Study 35194918 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anal anaesthetic
Number of subjects: 23
Study 35194918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23